NDT Advance Access published online on February 22, 2006
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfl017
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medicine, University of Hong Kong, Hong Kong, China
* To whom correspondence should be addressed. Background. TGF- Methods. Human proximal renal tubular epithelial cells (HK-2 cells) were incubated with 5, 10, 20 or 30 mM D-glucose for up to 3 weeks either in the presence or absence of TSP-1 blocking peptide. In separate studies HK-2 cells were incubated with exogenous TSP-1 (0-10 ng/ml) or TGF- Results. Elevated glucose concentrations increased TSP-1 synthesis, which was associated with reduced cell proliferation, increased TGF- Conclusions. TSP-1 plays an important role in the induction of matrix synthesis by high glucose concentrations in human proximal renal tubular epithelial cells, through TGF-
Received May 10, 2005
Accepted January 13, 2006
Original Article
Elevated glucose induction of thrombospondin-1 up-regulates fibronectin synthesis in proximal renal tubular epithelial cells through TGF-
Susan Yung 1,
Candice YY Lee 1,
Qing Zhang 1,
Shuk Kei Lau 1,
Ryan CW Tsang 1,
and
Tak Mao Chan 1 *
1 dependent and TGF-1 independent pathways
Tak Mao Chan, E-mail: dtmchan{at}hkucc.hku.hk
Abstract 
1 bioactivation, consequent to the interaction of latent TGF-1 with thrombospondin-1 (TSP-1), correlates with matrix accumulation in mesangial cells. Tubulointerstitial damage predicts poor renal survival. There is little data on TGF-1 bioactivation and matrix synthesis in human proximal renal tubular epithelial cells under the influence of high glucose concentrations. This study thus investigates the role of TSP-1 in mediating elevated glucose-induction of TGF-1 bioactivation and fibronectin (FN) synthesis in human proximal tubular epithelial cells.1 (0-10 ng/ml) for 24 h. Cell proliferation was assessed by [3H]-thymidine incorporation. TGF-1 transcript, secretion and bioactivity were investigated by quantitative real-time PCR, ELISA and the MLEC bioassay respectively. TSP-1 and FN synthesis were assessed by quantitative real-time PCR, ELISAs and Western blot analysis.1 bioactivity, and stimulation of FN synthesis. The inclusion of TSP-1 blocking peptide to cells stimulated with elevated glucose concentration abrogated activation of TGF-1 and induction of FN secretion. Exogenous TSP-1 increased bioactive TGF-1 in HK-2 cells to initiate FN accumulation. Of interest is our observation that TSP-1 also increased matrix synthesis through a mechanism independent of TGF-1. TGF-1 in turn modulated TSP-1 synthesis, indicative of an autocrine loop between TSP-1 and TGF-1.1 dependent and TGF-1 independent pathways. Pharmacological intervention targeting increased TSP-1 expression may interrupt the pathogenesis of diabetic nephropathy.1; thrombospondin-1.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Kosugi, M. Heinig, T. Nakayama, T. Connor, Y. Yuzawa, Q. Li, W. W. Hauswirth, M. B. Grant, B. P. Croker, M. Campbell-Thompson, et al. Lowering Blood Pressure Blocks Mesangiolysis and Mesangial Nodules, but Not Tubulointerstitial Injury, in Diabetic eNOS Knockout Mice Am. J. Pathol., April 1, 2009; 174(4): 1221 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Daniel, K. Schaub, K. Amann, J. Lawler, and C. Hugo Thrombospondin-1 Is an Endogenous Activator of TGF-{beta} in Experimental Diabetic Nephropathy In Vivo Diabetes, December 1, 2007; 56(12): 2982 - 2989. [Abstract] [Full Text] [PDF]
|
|